UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Meeting Report: WHO consultation on considerations for regulatory expectations of Zika virus vaccines for use during an emergency

Vaccine, 2019-11, Vol.37 (50), p.7443-7450

2019

Volltextzugriff (PDF)

DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccine Encoding Thrombospondin-Related Adhesion Protein but Not Circumsporozoite Protein Partially Protects Healthy Malaria-Naive Adults against Plasmodium falciparum Sporozoite Challenge

Infection and Immunity, 2006-10, Vol.74 (10), p.5933-5942

2006

Volltextzugriff (PDF)

A Cationic Lipid-Formulated Plasmid DNA Vaccine Confers Sustained Antibody-Mediated Protection against Aerosolized Anthrax Spores

Proceedings of the National Academy of Sciences - PNAS, 2004-09, Vol.101 (37), p.13601-13606

2004

Volltextzugriff (PDF)

A novel malaria protein, Pfs28, and Pfs25 are genetically linked and synergistic as falciparum malaria transmission-blocking vaccines

Infection and Immunity, 1997-03, Vol.65 (3), p.1109-1113

1997

Volltextzugriff (PDF)

Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial

Infection and immunity, 2001-03, Vol.69 (3), p.1536-1546

2001

Volltextzugriff (PDF)

Transmission-Blocking Activity of a Chitinase Inhibitor and Activation of Malarial Parasite Chitinase by Mosquito Protease

Proceedings of the National Academy of Sciences - PNAS, 1993-05, Vol.90 (9), p.4266-4270

1993

Volltextzugriff (PDF)

Developmental arrest of the human malaria parasite Plasmodium falciparum within the mosquito midgut via CTRP gene disruption

Molecular microbiology, 2000-04, Vol.36 (1), p.1-9

2000

Volltextzugriff (PDF)

A Family of Erythrocyte Binding Proteins of Malaria Parasites

Proceedings of the National Academy of Sciences - PNAS, 1992-08, Vol.89 (15), p.7085-7089

1992

Volltextzugriff (PDF)

Sporadic urban leptospirosis

Annals of internal medicine, 1996-11, Vol.125 (10), p.794

1996

Volltextzugriff (PDF)

Phase I/IIa Safety, Immunogenicity, and Efficacy Trial of NYVAC-Pf7, a Pox-Vectored, Multiantigen, Multistage Vaccine Candidate for Plasmodium falciparum Malaria

The Journal of infectious diseases, 1998-06, Vol.177 (6), p.1664-1673

1998

Volltextzugriff (PDF)

Shotgun DNA microarrays and stage‐specific gene expression in Plasmodium falciparum malaria

Molecular microbiology, 2000-01, Vol.35 (1), p.6-14

2000

Volltextzugriff (PDF)

Immunogenicity and Efficacy in Aotus Monkeys of Four Recombinant Plasmodium falciparum Vaccines in Multiple Adjuvant Formulations Based on the 19-Kilodalton C Terminus of Merozoite Surface Protein 1

Infection and Immunity, 2000-04, Vol.68 (4), p.2215-2223

2000

Volltextzugriff (PDF)

Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive, -exposed, and/or -rechallenged Aotus vociferans monkeys

Infection and immunity, 2000-03, Vol.68 (3), p.1418-1427

2000

Volltextzugriff (PDF)

Plasmodium malariae Infection in an Asymptomatic 74-Year-Old Greek Woman with Splenomegaly

The New England journal of medicine, 1998-02, Vol.338 (6), p.367-371

1998

Volltextzugriff (PDF)

A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia

The American journal of tropical medicine and hygiene, 1998-02, Vol.58 (2), p.211-219

1998

Volltextzugriff (PDF)

Antibodies to Malaria Vaccine Candidates Pvs25 and Pvs28 Completely Block the Ability of Plasmodium vivax To Infect Mosquitoes

Infection and Immunity, 2000-12, Vol.68 (12), p.6618-6623

2000

Volltextzugriff (PDF)

A region of Plasmodium falciparum antigen Pfs25 that is the target of highly potent transmission-blocking antibodies

Infection and immunity, 2000-10, Vol.68 (10), p.5530-5538

2000

Volltextzugriff (PDF)

Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates

Molecular medicine (Cambridge, Mass.), 1998-12, Vol.4 (12), p.772-782

1998

Volltextzugriff (PDF)

A DNA-Based Vaccine for the Prevention of Human Cytomegalovirus-Associated Diseases

Human vaccines, 2005-01, Vol.1 (1), p.16-23

2005

Volltextzugriff (PDF)

Malaria vaccine R&D in the Decade of Vaccines: Breakthroughs, challenges and opportunities

Vaccine, 2013-04, Vol.31, p.B233-B243

2013

Volltextzugriff (PDF)

CpG Oligodeoxynucleotide and Montanide ISA 51 Adjuvant Combination Enhanced the Protective Efficacy of a Subunit Malaria Vaccine

Infection and Immunity, 2004-02, Vol.72 (2), p.949-957

2004

Volltextzugriff (PDF)

Saccharomyces cerevisiae recombinant Pfs25 adsorbed to alum elicits antibodies that block transmission of Plasmodium falciparum

Infection and Immunity, 1994-12, Vol.62 (12), p.5576-5580

1994

Volltextzugriff (PDF)

NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria

Infection and Immunity, 1996-09, Vol.64 (9), p.3833-3844

1996

Volltextzugriff (PDF)

Saccharomyces cerevisiae-Secreted Fusion Proteins Pfs25 and Pfs28 Elicit Potent Plasmodium falciparum Transmission-Blocking Antibodies in Mice

Infection and Immunity, 1998-01, Vol.66 (1), p.59-64

1998

Volltextzugriff (PDF)

Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1

Infection and Immunity, 1996-07, Vol.64 (7), p.2716-2723

1996

Volltextzugriff (PDF)

1 – 25 von 592

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(535)
Mit Volltextzugriff
(501)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(592)

Erscheinungsjahr

n.n

Thema

Science & Technology
(329)
Life Sciences & Biomedicine
(305)
Humans
(294)
Biological And Medical Sciences
(228)
Female
(201)
Male
(194)
Animals
(169)
Adult
(141)
Medical Sciences
(130)
Fundamental And Applied Biological Sciences. Psychology
(124)
Immunology
(114)
Social Sciences
(112)
Human
(101)
Psychology
(98)
Infectious Diseases
(96)
Adolescent
(81)
Middle Aged
(81)
Family Studies
(80)
Psychology, Clinical
(77)
Plasmodium Falciparum
(64)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Meeting Report: WHO consultation on considerations for regulatory expectations of Zika virus vaccines for use during an emergency

DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccine Encoding Thrombospondin-Related Adhesion Protein but Not Circumsporozoite Protein Partially Protects Healthy Malaria-Naive Adults against Plasmodium falciparum Sporozoite Challenge

A Cationic Lipid-Formulated Plasmid DNA Vaccine Confers Sustained Antibody-Mediated Protection against Aerosolized Anthrax Spores

A novel malaria protein, Pfs28, and Pfs25 are genetically linked and synergistic as falciparum malaria transmission-blocking vaccines

Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial

Transmission-Blocking Activity of a Chitinase Inhibitor and Activation of Malarial Parasite Chitinase by Mosquito Protease

Developmental arrest of the human malaria parasite Plasmodium falciparum within the mosquito midgut via CTRP gene disruption

A Family of Erythrocyte Binding Proteins of Malaria Parasites

Sporadic urban leptospirosis

Phase I/IIa Safety, Immunogenicity, and Efficacy Trial of NYVAC-Pf7, a Pox-Vectored, Multiantigen, Multistage Vaccine Candidate for Plasmodium falciparum Malaria

Shotgun DNA microarrays and stage‐specific gene expression in Plasmodium falciparum malaria

Immunogenicity and Efficacy in Aotus Monkeys of Four Recombinant Plasmodium falciparum Vaccines in Multiple Adjuvant Formulations Based on the 19-Kilodalton C Terminus of Merozoite Surface Protein 1

Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive, -exposed, and/or -rechallenged Aotus vociferans monkeys

Plasmodium malariae Infection in an Asymptomatic 74-Year-Old Greek Woman with Splenomegaly

A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia

Antibodies to Malaria Vaccine Candidates Pvs25 and Pvs28 Completely Block the Ability of Plasmodium vivax To Infect Mosquitoes

A region of Plasmodium falciparum antigen Pfs25 that is the target of highly potent transmission-blocking antibodies

Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates

A DNA-Based Vaccine for the Prevention of Human Cytomegalovirus-Associated Diseases

Malaria vaccine R&D in the Decade of Vaccines: Breakthroughs, challenges and opportunities

CpG Oligodeoxynucleotide and Montanide ISA 51 Adjuvant Combination Enhanced the Protective Efficacy of a Subunit Malaria Vaccine

Saccharomyces cerevisiae recombinant Pfs25 adsorbed to alum elicits antibodies that block transmission of Plasmodium falciparum

NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria

Saccharomyces cerevisiae-Secreted Fusion Proteins Pfs25 and Pfs28 Elicit Potent Plasmodium falciparum Transmission-Blocking Antibodies in Mice

Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1

Suchergebnisse filtern